Bioventus Inc reports results for the quarter ended in March - Earnings Summary

Bioventus

16/05/2023 22:02

* Bioventus Inc  BVS.OQ  reported a quarterly adjusted loss
of 26
cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 15 cents per share.
    * Revenue rose 1.5% to $119.06 million from a year ago;
analysts
expected $116.58 million. 
    * Bioventus Inc's reported EPS for the quarter was a loss of
$2.24​.
    * The mean earnings estimate of analysts had fallen by
about 300%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Bioventus Inc shares had risen by 15.0% this quarter and
lost 52.9% so far this year.
    * The company reported a quarterly loss of $139.15 million.
    * Wall Street's median 12-month price target for Bioventus
Inc is
$4.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.15          -0.26          Missed
 Dec. 31 2022      0.05           -0.06          Missed
 Sep. 30 2022      0.12           0.08           Missed
 Jun. 30 2022      0.16           0.10           Missed